This paper is in the following e-collection/theme issue:

Pilot studies (non-ehealth) (114) Fast-track articles (8) Journal Club CATCH-IT Reports* (7) Mednet conference papers (Section Editor: Hans v.d.Slikke)* (4)

Published on in Vol 9 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/60051, first published .
A Very Low–Carbohydrate Program in Adults With Metabolic Dysfunction–Associated Steatotic Liver Disease and Phospholipase Domain–Containing Protein 3 Risk Genotype: Pre-Post Intervention Study

A Very Low–Carbohydrate Program in Adults With Metabolic Dysfunction–Associated Steatotic Liver Disease and Phospholipase Domain–Containing Protein 3 Risk Genotype: Pre-Post Intervention Study

A Very Low–Carbohydrate Program in Adults With Metabolic Dysfunction–Associated Steatotic Liver Disease and Phospholipase Domain–Containing Protein 3 Risk Genotype: Pre-Post Intervention Study

Authors of this article:

Laura R Saslow1 Author Orcid Image ;   Jamie Krinock1 Author Orcid Image ;   Alison O'Brien1 Author Orcid Image ;   Kaitlyn Raymond1 Author Orcid Image ;   Hovig Bayandorian Author Orcid Image ;   Judith T Moskowitz2 Author Orcid Image ;   Jennifer Daubenmier3 Author Orcid Image ;   Antonino Oliveri4 Author Orcid Image ;   Deanna J Marriott5 Author Orcid Image ;   Dina H Griauzde6, 7 Author Orcid Image ;   Elizabeth K Speliotes4, 8 Author Orcid Image
Article Authors Cited by (2) Tweetations Metrics

Journals

  1. Tincopa M, Speliotes E, Valenti L, Loomba R. Metabolic Dysfunction–Associated Steatotic Liver Disease and Metabolic Dysfunction–Associated Steatohepatitis–Related Fibrosis: Therapeutic Options and Approaches to Treatment. Annual Review of Medicine 2026;77(1):103 View
  2. Nada A, Elashkar A, Elbahr O, Atef M, Mohammed T, Elabd N, Othman W. Potential association between PNPLA3 rs738409 and hepatocellular carcinoma in Egyptian patients with type 2 diabetes mellitus. Egyptian Liver Journal 2026;16(1) View